 Diuretic agents beta-blockers treatment hypertension Benzothiadiazine diuretic agents beta-adrenergic receptor-blocking drugs main groups drugs mild hypertension questions relative efficacy morbidity mortality vascular disease addition effect blood pressure Attention unfavorable metabolic effects diuretic drugs proven value beta-adrenergic receptor blockade secondary prevention myocardial infarction trials drugs classes Medical Research Council trial International Prospective Primary Prevention Study Hypertension Heart Attack Primary Prevention Hypertension trial Metoprolol Atherosclerosis Prevention Hypertension study trials Medical Research Council questions relative efficacy classes drugs stroke smokers nonsmokers Overall little evidence reduction morbidity mortality myocardial infarction predicted advantage beta-adrenergic receptor blockade diuretic therapy sufficient hints differential benefit performance trials